Shijiazhuang Pingan Hospital

  1. Brief introduction of the hospital
  Shijiazhuang Ping An Hospital was founded in 1987. After more than 30 years of unremitting efforts, it has developed into a comprehensive specialized hospital with strong technical force and distinctive features of TRADITIONAL Chinese medicine, integrating clinical practice, scientific research and teaching. It is the affiliated hospital of Hebei Medical University, the designated hospital of provincial and municipal medical insurance, and the national "11th Five-Year Plan" key Chinese medicine specialty construction unit. The hospital covers an area of 110 mu, with a total construction area of 70,000 square meters. Provide patients with a warm, convenient and safe medical environment. It has more than 700 employees, including more than 600 health technicians. Hospital set up 1100 beds, the opening of a blood disease, oncology, rheumatism, kidney disease, peripheral vascular disease, obstetrics and gynecology, surgery, orthopedics, cardio-cerebrovascular disease, diabetes, digestive diseases, ent, ophthalmology, etc in 22 clinical departments and clinical laboratory, radiology, CT room, radiation therapy, therapeutic room, ultrasonic knife, colour to exceed, endoscopic examination room, interventional treatment center, department of medical and 15, including clinical laboratory and construction of molecular biology, cell biology, genetics and other three cutting-edge research. It can carry out cutting-edge experiments and diagnostic techniques in molecular biology, genetics, cell biology, etc., and its diagnostic level ranks among the top in China. In addition, hematology was rated as one of the key TCM specialties in the 11th Five-Year Plan in 2007, rheumatology as one of the key TCM specialties in the 12th Five-year Plan in 2011, and oncology and rheumatology as one of the key TCM specialties in Hebei Province in 2011.

  The hospital to "integrity, dedication; Diligence, innovation "as enterprise spirit, always adhere to the" medical high level, high scientific level and service level "of hospital policy, closely around the" taking patient as the center, continuously improve the quality of medical care services, efforts to create the people satisfied with the hospital "development goals, the pursuit of social benefit, maintain the interests of the masses, to build a harmonious doctor-patient relationship in the hospital management work first. In 20 years, the hospital always adhere to the "people-oriented" and "heavy degree not only education, greater capacity" of the concept of choose and employ persons, and gradually formed a perfect introduction and training of high-level personnel mechanism and "condensed, incentive, competition, constraints," talent management mechanism, the establishment of a high level expert group and a high level of professional and technical personnel.

  2.Introduction of hematology department
  Shijiazhuang peace hospital blood disease of traditional Chinese medicine (TCM) is the national key specialty, national key clinical blood disease specialist, key specialty of traditional Chinese medicine, combined Chinese and western medicine in hebei province, hebei province, director of the institute of hematology professional committee member units, traditional Chinese medicine, director of the institute of hematology professional committee members units in hebei province, hebei medical university affiliated hospital, hebei medical university graduate student training units, medical center at the Chinese academy of traditional Chinese and western medicine combined with diseases of the blood. It has six wards and 300 beds, and has three laboratories, namely, clinical blood laboratory, leukemia Laboratory, anemia laboratory and blood clotting laboratory, equipped with laminar flow wards. It has three cutting-edge laboratories, namely molecular biology, genetics and cell culture, with 120 medical staff and 42 senior professionals, including 4 master supervisors, 5 chief physicians, 12 associate chief physicians and 20 doctors and masters. Since its establishment, it has obtained 4 scientific research achievements of ministry, province and city, and published nearly 50 papers at home and abroad. More than 40,000 blood disease patients from more than 30 provinces, autonomous regions, Hong Kong, Taiwan and 14 countries have been admitted and treated. Main specialized equipment has eight color flow cytometry instrument, real time quantitative PCR and bone marrow cells form the computer show like analyzer, pathology analysis system, bone marrow cell separator, automatic blood count analyzer, automatic biochemistry analyzer, blood coagulation analyzer, such as multi-functional micro video system, which can in cell morphology, molecular biology, genetics and other levels of blood disease diagnosis, advanced in China. This specialty integrates medical treatment, teaching and scientific research into one. With its first-class expert team, strong technical strength, remarkable clinical efficacy and high-quality medical service, it has become a national large-scale characteristic specialty of integrated Traditional Chinese and Western medicine in the treatment of blood diseases, and its comprehensive strength has reached the advanced level in China.

  3. Leading diseases in hematology department
  With aplastic anemia, various types of leukemia, myelodysplastic syndrome, primary thrombocytopenic purpura, multiple myeloma, allergic purpura, myelofibrosis, autoimmune hemolytic anemia, paroxysmal sleep hemoglobinuria, lymphoma as the leading diseases.

  4. Characteristic diagnosis and treatment technology of hematopathy

  Blood cell regeneration therapy
  To sum up the successful experience of Chinese medicine in the treatment of regenerated anemia, a series of pure Chinese medicine preparations have been developed to promote the recovery of bone marrow hematopoietic function, and combined with Chinese medicine point magnetic therapy, synergistic effect, regulating qi and blood, supporting poison and pathogens, nourishing kidney essence and generating medullated blood, obviously improving the curative effect of aplastic anemia.

  Blood regulation therapy
  By combining the traditional Chinese medicine theory with the new achievements of modern research on Traditional Chinese medicine, MDS was treated by TCM internal medicine, TCM foot bath and TCM ion permeation, so as to restore normal hematopoiesis and control abnormal hematopoiesis. This clinical research project is listed as a scientific research project of The State Administration of Traditional Chinese Medicine, making our hospital the only hospital in China that has approved a project to study the treatment of myelodysplastic syndrome with Traditional Chinese medicine.

  Three - step therapy for leukemia
  Our latest clinical research shows the trilogy of acute leukemia treatment, the first step in cold blood detoxification medicine combined with chemotherapy hematology relief, supporting the second step using traditional Chinese medicine combined with chemotherapy or AAA genetics or molecular biology, the third step by detoxifying eliminate pathogenic TCM combining cells immunotherapy to remove tiny residual leukemia cells to effect a radical cure thoroughly.